Market research
PHG Koninklijke Philips NV ADR
NYSE USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 27B
- P/E ratio
- 20.62
- Analyst target
- 32.21
- Dividend yield
- 3.6%
- Beta
- 0.91
Profile
Company facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US5004723038
- Market cap
- 27B
- P/E ratio
- 20.62
- Analyst target
- 32.21
- Dividend yield
- 3.6%
- Beta
- 0.91
About
About Koninklijke Philips NV ADR
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the PHG discussion.
5 years, 4 months ago
Koninklijke Philips N.V is currently in a long term downtrend where the price is trading 12.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.4.
Koninklijke Philips N.V's total revenue rose by 0.7% to $6B since the same quarter in the previous year.
Its net income has increased by 8.5% to $603M since the same quarter in the previous year.
Finally, its free cash flow grew by 75.9% to $2B since the same quarter in the previous year.
Based on the above factors, Koninklijke Philips N.V gets an overall score of 4/5.